Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
765.410.07%
QQQ
717.380.14%
BTC/USD
79121.030.8514%
DIA
527.560.09%
GLD
398.850.22%
TLT
82.140.07%

Compass Pathways PLC

CMPSNASDAQ
Trade with Public
Trade with Public
$14.04
0.775.8%
At close: Sep 8, 5:00 PM EST
$14.36
0.322.28%
After Hours: 7:56 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Compass Pathways Analyst Price Targets

Wall Street analyst price targets and consensus rating for Compass Pathways (CMPS).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

13Buy
Consensus RatingBuy# Analysts13Avg. Consensus PT$22Upside to Avg. PT+53.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026HC Wainwright & Co.Patrick R. TrucchioPT CutBuy$70→$65
Aug 6, 2026Morgan StanleyJudah FrommerPT RaiseOverweight$17→$18
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Compass Pathways (NASDAQ:CMPS) with a Buy and lowers the price target from $70 to $65.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

Morgan Stanley analyst Judah Frommer maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and raises the price target from $17 to $18.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21

RBC Capital analyst Leonid Timashev maintains Compass Pathways (NASDAQ:CMPS) with a Outperform and lowers the price target from $22 to $21.
Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on Compass Pathways, Raises Price Target to $22

B. Riley Securities analyst Madison El-Saadi maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $17 to $22.
Benzinga Newsdesk

PRO
Wells Fargo Initiates Coverage On Compass Pathways with Equal-Weight Rating, Announces Price Target of $13

Wells Fargo analyst Benjamin Burnett initiates coverage on Compass Pathways (NASDAQ:CMPS) with a Equal-Weight rating and announces Price Target of $13.
Benzinga Newsdesk

Why Is Neuronetics Stock Soaring Monday?

BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. Read the details here.
Vandana Singh

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved